Intervacc (Q2 initial take): Few surprises – all eyes on the label extension - Redeye
Bildkälla: Stockfoto

Intervacc (Q2 initial take): Few surprises – all eyes on the label extension - Redeye

Q2 contained few surprises, and the small absolute figures remain of limited importance to our estimates. Instead, we focus on the recently submitted label extension, which we regard as a key catalyst for Strangvac’s commercial adoption.

Q2 contained few surprises, and the small absolute figures remain of limited importance to our estimates. Instead, we focus on the recently submitted label extension, which we regard as a key catalyst for Strangvac’s commercial adoption.
Börsvärldens nyhetsbrev